Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis

dc.contributor.authorWisztorski, Maxence
dc.contributor.authorAboulouard, Soulaimane
dc.contributor.authorRoussel, Lucas
dc.contributor.authorDuhamel, Marie
dc.contributor.authorSaudemont, Philippe
dc.contributor.authorCardon, Tristan
dc.contributor.authorNarducci, Fabrice
dc.contributor.authorRobin, Yves Marie
dc.contributor.authorLemaire, Anne Sophie
dc.contributor.authorBertin, Delphine
dc.contributor.authorHajjaji, Nawale
dc.contributor.authorKobeissy, Firas H.
dc.contributor.authorLeblanc, Éric
dc.contributor.authorFournier, Isabelle
dc.contributor.authorSALZET, Michel
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:38:35Z
dc.date.available2025-01-24T11:38:35Z
dc.date.issued2023
dc.description.abstractOvarian cancer is the leading cause of death from gynecologic cancer worldwide. High-grade serous carcinoma (HGSC) is the most common and deadliest subtype of ovarian cancer. While the origin of ovarian tumors is still debated, it has been suggested that HGSC originates from cells in the fallopian tube epithelium (FTE), specifically the epithelial cells in the region of the tubal-peritoneal junction. Three main lesions, p53 signatures, STILs, and STICs, have been defined based on the immunohistochemistry (IHC) pattern of p53 and Ki67 markers and the architectural alterations of the cells, using the Sectioning and Extensively Examining the Fimbriated End Protocol. In this study, we performed an in-depth proteomic analysis of these pre-neoplastic epithelial lesions guided by mass spectrometry imaging and IHC. We evaluated specific markers related to each preneoplastic lesion. The study identified specific lesion markers, such as CAVIN1, Emilin2, and FBLN5. We also used SpiderMass technology to perform a lipidomic analysis and identified the specific presence of specific lipids signature including dietary Fatty acids precursors in lesions. Our study provides new insights into the molecular mechanisms underlying the progression of ovarian cancer and confirms the fimbria origin of HGSC. © 2023, The Author(s).
dc.identifier.doihttps://doi.org/10.1038/s41419-023-06165-5
dc.identifier.eid2-s2.0-85173556516
dc.identifier.pmid37775701
dc.identifier.urihttp://hdl.handle.net/10938/29083
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.ispartofCell Death and Disease
dc.sourceScopus
dc.subjectCystadenocarcinoma, serous
dc.subjectFallopian tube neoplasms
dc.subjectFallopian tubes
dc.subjectFemale
dc.subjectHumans
dc.subjectOvarian neoplasms
dc.subjectProteomics
dc.subjectTumor suppressor protein p53
dc.subjectProtein p53
dc.subjectAdult
dc.subjectAged
dc.subjectArticle
dc.subjectCancer growth
dc.subjectClinical article
dc.subjectEarly cancer
dc.subjectEpithelium lesion
dc.subjectHuman
dc.subjectHuman cell
dc.subjectHuman tissue
dc.subjectImmunohistochemistry
dc.subjectLipidomics
dc.subjectOvary cancer
dc.subjectUterine tube disease
dc.subjectChemistry
dc.subjectCystadenocarcinoma
dc.subjectFallopian tube
dc.subjectFallopian tube tumor
dc.subjectGenetics
dc.subjectOvary tumor
dc.subjectPathology
dc.titleFallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-544.pdf
Size:
6.04 MB
Format:
Adobe Portable Document Format